- S&P/TSX16,089.33-0.96%
- S&P 5002,800.71-1.90%
- DOW25,502.32-1.77%
- CAD/USD0.7458-0.0000%
- CRUDE OIL58.97-1.68%
- BTC-CAD5,345.00+0.25%
- GOLD FUTURES1,313.40+0.47%
- RUSSELL 20001,505.92-3.62%
- 10-Yr Bond2.4550-3.23%
- NASDAQ7,642.67-2.50%
- VOLATILITY16.48+20.91%
- FTSE7,207.59-2.01%
- NIKKEI 22521,627.34+0.09%
- CAD/EUR0.65950.00%
Crowded Hedge Fund Positions
4.74k followers • 30 symbols Watchlist by Yahoo Finance
Follow this list to discover and track stocks with highest percentage of hedge fund ownership.
30 Symbols
Get the Yahoo Finance app
- Free real-time data
- News and price alerts
- Add and edit holdings
- Track performance
- Create multiple watchlists
- Zacks•8 hours ago
Altice USA (ATUS) Up 1.6% Since Last Earnings Report: Can It Continue?
Altice USA (ATUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Motley Fool•yesterday
Here's Why Shares of GOL Linhas Aereas Dropped on Friday
An offering designed to pay down debt came in smaller than first anticipated.
- Zacks•yesterday
Levi Strauss Goes Public...Again
Now after 166 years of operation they decide to open up ownership of the company to the public, again.
- Zacks•yesterday
Mortgage Rates Lowest in a Year: Top 4 Housing Picks
The housing space looks promising as mortgage rates drop to the lowest level in a year.
- Zacks•yesterday
Jack In The Box (JACK) Down 2.8% Since Last Earnings Report: Can It Rebound?
Jack In The Box (JACK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Reuters•2 days ago
UPDATE 5-Biogen scraps two Alzheimer drug trials, wipes $18 bln from market value
CHICAGO/TOKYO, March 21 (Reuters) - Biogen Inc and partner Eisai Co Ltd are ending two late-stage trials of their experimental Alzheimer's disease drug aducanumab, a major setback in the quest to find a treatment for the mind-wasting disease and a blow to Biogen, which lost more than $18 billion of its value on Thursday. Experts had seen aducanumab as one of the last tests of the hypothesis that removing sticky deposits of amyloid from the brain of patients in earlier stages of the lethal disease could stave off its ravages, which include loss of memory and the ability to care for oneself. Biogen shares fell nearly 30 percent to $225.70, its largest drop since February 2005, when they fell nearly 43 percent to close at $38.65 on Nasdaq.
- Motley Fool•2 days ago
Why Shares of Intelsat Plunged on Thursday
Government officials are in no hurry to decide on a controversial proposed spectrum sale.
Motley Fool•3 days agoDSW Inc. (DSW) Q4 2018 Earnings Conference Call Transcript
DSW earnings call for the period ending December 31, 2018.
- Motley Fool•3 days ago
DSW's Lackluster Fourth Quarter Disappoints Investors
But its stock still looks cheap relative to its long-term growth potential.
- Market Realist•3 days ago
Wendy’s Stock Falls after Mizuho Downgrade
Mizuho Downgrades Wendy’s from 'Buy' to 'Neutral'(Continued from Prior Part)Stock performance The Mizuho downgrade appears to have led a fall in Wendy’s (WEN) stock price. Today, at 10:30 AM EST, the company was trading ~1.2% lower from its
- Market Realist•3 days ago
Mizuho Downgrades Wendy’s from ‘Buy’ to ‘Neutral’
Mizuho Downgrades Wendy’s from 'Buy' to 'Neutral'Wendy’s downgradeMizuho downgraded Wendy’s (WEN) from “buy” to “neutral” today and also lowered its 12-month price target from $20 to $18. The new price target implies an upside
- Market Realist•3 days ago
Tesla Stock: Elon Musk and SEC Legal Battle Takes a Toll
Are Elon Musk and Tesla Boosting Q1 Car Orders?TeslaSince 2011, Tesla (TSLA) stock has yielded positive yearly returns in all of the years except in 2016. In 2016, the company unveiled Model 3—its first mass-production electric car. Tesla also
- Market Realist•3 days ago
Electric Vehicles and Trump’s Policies: Gauging the Impact
Can US Companies Keep Both Trump and Investors Happy?(Continued from Prior Part)Electric vehicles To complicate things further, automakers need to conserve cash and spend it judiciously on new technologies such as autonomous vehicles. Automakers have
- Zacks•3 days ago
KB Home (KBH) Gears Up for Q1 Earnings: What's in the Cards?
Lower revenues, margins and additional marketing expenses will likely hurt KB Home's (KBH) fiscal first-quarter results.
- The Wall Street Journal•3 days ago
[$$] VC Daily: Peloton Faces a Music Rap | Dueling Models at Stitch Fix and Glossier
VC Daily: Peloton Faces a Music Rap | Dueling Models at Stitch Fix and Glossier Good day. Adding entertainment content to your app can make for some contentious dealings. Peloton Interactive Inc. is a popular fitness startup that sells stationary bicycles for more than $2,000, plus various accessories.
- Barrons.com•3 days ago
How Small Investors Can Play Lyft and Other IPOs
GSV Capital’s strategy is to invest in late-stage private companies and sell them within 18 months of their IPOs. Lyft is its fifth-largest holding.
Yahoo Finance•4 days agoDSW has mixed quarter, Michaels climbs, Nvidia’s new plans
DSW, Michaels Companies, Nvidia, Netflix, Apple, Budweiser and Keurig Dr. Pepper are the companies to watch.
- Motley Fool•4 days ago
Why Advanced Micro Devices, StoneCo, and Sibanye Gold Jumped Today
Smart strategic moves and favorable markets helped lift these stocks.
- The Wall Street Journal•4 days ago
[$$] DSW to Rebrand in Shift to More In-House Lines
DSW, now called Designer Brands, will operate retail stores under the DSW Designer Shoe Warehouse, The Shoe Company and Shoe Warehouse banners and will produce items under Camuto Group, which it bought in November. The announcements were made at an investor event Tuesday, which came as the retailer posted a surprise loss in its latest period and projected profit for the current fiscal year below analysts’ expectations. Making its own exclusive line of products will help the company stem the flow of sales going directly to vendors by offering consumers products they can only get in DSW stores or online, Mr. Rawlins said.
- The Canadian Press•4 days ago
DSW posts surprise 4Q loss, will rename co. Designer Brands
NEW YORK — Shoe chain DSW Inc. on Tuesday reported a surprise loss for its fiscal fourth quarter as it digested costs from acquisitions.DSW, based in Columbus, Ohio, also offered a disappointing earnings forecast for the current year, which drove shares down more than 13 per cent.The results come as the chain said it plans to change its corporate name to Designer Brands Inc. as it expands its offerings. It's slated to change its ticker symbol to DBI on April 2.Last year, the company purchased Camuto Group, a shoe manufacturer that owns licensing rights for the Jessica Simpson footwear business and footwear and handbag licenses for Lucky Brand.DSW also has been adding services like nail salons, and it plans to build exclusive brands and products.The moves come as Amazon has been increasing its market share in shoes, while key rival Payless ShoeSource is closing its 2,500 stores in North America.DSW posted a fiscal fourth-quarter loss of $45.7 million, after reporting a profit in the same period a year earlier.On a per-share basis, the company said it had a loss of 58 cents. Losses, adjusted for one-time gains and costs, were 7 cents per share.The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 3 cents per share.The footwear and accessories retailer with nearly 1,000 locations posted revenue of $843.4 million in the period, which also fell short of Street forecasts. Four analysts surveyed by Zacks expected $850.7 million.For the year, the company swung to an annual loss of $20.5 million, or 26 cents per share. Revenue was reported as $3.18 billion.Looking ahead, for the current fiscal year DSW expects earnings per share in the range of $1.80 to $1.90 per share. Analysts expected $1.94 per share, according to FactSet.The company said it expects earnings share to be from $2.65 per share to $2.75 per share for fiscal 2021. Analysts forecast $2.12 per share, according to FactSet.DSW's share fell $3.40 to $21.96 in afternoon trading._____Elements of this story were generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DSW at https://www.zacks.com/ap/DSWThe Associated Press
Bloomberg•4 days agoBuffett-Backed StoneCo Soars on Strong Results
The Brazilian firm, which is backed by Warren Buffett, more than doubled its active clients during the quarter and said it is accelerating the rollout of new products and services. “More importantly, the company shared an encouraging qualitative message in the conference call, conveying that its plans have not been hindered by competition,” Credit Suisse analyst Lucas Lopes said in a note to clients. With the stock up 73 percent since its initial public offering in October, some investors may start to wonder if most of the tailwinds are already priced in.
- Barrons.com•4 days ago
DSW Stock Takes a Tumble as the Other Shoe Drops
Unlike many retailers that have bounced back from December’s steep selloff, the show retailer’s shares are still trailing the broader market in 2019, falling more than 10%
